CAPLIPOINT - Caplin Point Laboratories

Caplin Point Laboratories

CAPLIPOINT · Pharma > Pharmaceuticals & Drugs · Chairman: C C Paarthipan · MD: Sridhar Ganesan · Listing date: June 23, 2014 · Employees: 1675 · Chennai · http://www.caplinpoint.net

Stock Price vs Company Growth

1.3%

0.7%

3.3%

50.3%

50.1%

26.7%

23.2%

10y

27.9%

all

43.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 2,589 1.3%

1,676

2,700

Company Overview

Sales

2,187 Cr

Growth: 10.7%

Profit after Tax

641 Cr

Growth: 4.5%

Mid Cap

19,681 Cr

P/E: 30.8x

Industry P/E: 32.3x

Fundamentals

Sales (Cr)	₹ 2,187
Growth	10.7%
EBITDA	34.8%
P/S	9.0x
Dividend	0.3%
P/E	30.8x
Book Value	₹ 472
PEG Ratio	2.9x
ROE	19.6%
P/B	5.6x

Shareholding Pattern

Institutions

Promoters

P Vijayalakhsmi

23.64 %

Paarthipan C C

18.73 %

Ashok Gorkey Partheeban

11.96 %

Partheeban Vivek Siddarth

11.9 %

May India Property Private Limited

2.8 %

Others

Iepf

2.46 %

Visalatchi

2.22 %

Suresh Kumar Agarwal

1.32 %

Ashish Kacholia

1.16 %

Llp

0.7 %

Increase Decrease No change

Company Profile Detailed

Caplin Point Laboratories is engaged in manufacture of pharmaceuticals formulations. It is a fast-growing Indian pharmaceutical company with global reach, having a 100% export-oriented business. The company supplies a complete range of finished dosage forms. The company operates on a unique business model which predominantly caters to emerging markets of Latin America and Africa and a growing presence in regulated markets like the USA, Canada, Australia etc.

Belongs to (26 Indices) view more

Investors (50)

partheeb...

ashok.go...

liabilit...

Followers (28)

rohit66

damerla

bhaskar2